We came across a bullish thesis on ADMA Biologics, Inc. on Archive Invest’s Substack by Felix. In this article, we will summarize the bulls’ thesis on ADMA. ADMA Biologics, Inc.’s share was trading at $17.80 as of August 22nd. ADMA’s trailing and forward P/E were 20.94 and 28.99 respectively according to Yahoo Finance.
Adma Biologics (ADMA) has delivered a remarkable financial turnaround, with 2024 standing out as a pivotal year. Gross profit has compounded at an impressive 34% CAGR...
